[go: up one dir, main page]

CY2489B1 - Thermoplastic polymer membranes. - Google Patents

Thermoplastic polymer membranes.

Info

Publication number
CY2489B1
CY2489B1 CY0400090A CY0400090A CY2489B1 CY 2489 B1 CY2489 B1 CY 2489B1 CY 0400090 A CY0400090 A CY 0400090A CY 0400090 A CY0400090 A CY 0400090A CY 2489 B1 CY2489 B1 CY 2489B1
Authority
CY
Cyprus
Prior art keywords
thermoplastic polymer
polymer membranes
poly
hydroxypropylcellulose
polycaprolactone
Prior art date
Application number
CY0400090A
Other languages
English (en)
Inventor
Liang C Dong
Crystal Pollock
Patrick S-L Wong
Vincent Joseph Ferrari
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of CY2489B1 publication Critical patent/CY2489B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L67/00—Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers
    • C08L67/04—Polyesters derived from hydroxycarboxylic acids, e.g. lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
    • B01D71/06—Organic material
    • B01D71/48—Polyesters
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/08—Cellulose derivatives
    • C08L1/26—Cellulose ethers
    • C08L1/28—Alkyl ethers
    • C08L1/284—Alkyl ethers with hydroxylated hydrocarbon radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CY0400090A 1994-10-28 2004-12-17 Thermoplastic polymer membranes. CY2489B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/330,892 US5614578A (en) 1994-10-28 1994-10-28 Injection-molded dosage form

Publications (1)

Publication Number Publication Date
CY2489B1 true CY2489B1 (en) 2005-06-03

Family

ID=23291759

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0400090A CY2489B1 (en) 1994-10-28 2004-12-17 Thermoplastic polymer membranes.

Country Status (13)

Country Link
US (2) US5614578A (fr)
EP (2) EP1057478B1 (fr)
JP (1) JPH10508023A (fr)
KR (2) KR100451782B1 (fr)
AT (2) ATE203396T1 (fr)
AU (1) AU695739B2 (fr)
CA (1) CA2200746C (fr)
CY (1) CY2489B1 (fr)
DE (2) DE69521901T2 (fr)
ES (1) ES2203395T3 (fr)
NZ (1) NZ295982A (fr)
WO (1) WO1996013248A1 (fr)
ZA (1) ZA958892B (fr)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614578A (en) * 1994-10-28 1997-03-25 Alza Corporation Injection-molded dosage form
US5773500A (en) * 1996-05-14 1998-06-30 Amoco Corporation Flame retardant high temperature polyphthalamides having improved thermal stability
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
DK0946151T3 (da) * 1996-11-25 2006-08-28 Alza Corp Doseringsform med stigende dosisfrigivelse
WO1999018159A1 (fr) * 1997-10-06 1999-04-15 Alza Corporation Composition moulable par injection et produit manufacture a base de cette composition
US6251418B1 (en) 1997-12-18 2001-06-26 C.R. Bard, Inc. Systems and methods for local delivery of an agent
US6197324B1 (en) 1997-12-18 2001-03-06 C. R. Bard, Inc. System and methods for local delivery of an agent
WO1999040156A1 (fr) 1998-02-06 1999-08-12 Union Carbide Chemicals & Plastics Technology Corporation Compositions polymeres d'oxyde d'alkylene
US6099859A (en) 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
US6183466B1 (en) 1998-08-21 2001-02-06 Alza Corporation Dosage form comprising a capsule
US6099862A (en) 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
US6551613B1 (en) * 1998-09-08 2003-04-22 Alza Corporation Dosage form comprising therapeutic formulation
US6174547B1 (en) * 1999-07-14 2001-01-16 Alza Corporation Dosage form comprising liquid formulation
US6689121B1 (en) 1998-09-24 2004-02-10 C. R. Bard, Inc. Systems and methods for treating ischemia
US6458092B1 (en) 1998-09-30 2002-10-01 C. R. Bard, Inc. Vascular inducing implants
US6248112B1 (en) 1998-09-30 2001-06-19 C. R. Bard, Inc. Implant delivery system
US6432126B1 (en) 1998-09-30 2002-08-13 C.R. Bard, Inc. Flexible vascular inducing implants
US6251079B1 (en) 1998-09-30 2001-06-26 C. R. Bard, Inc. Transthoracic drug delivery device
US6692520B1 (en) 1998-12-15 2004-02-17 C. R. Bard, Inc. Systems and methods for imbedded intramuscular implants
MXPA01006108A (es) * 1998-12-17 2002-09-18 Alza Corp Conversion de capsulas de gelatina rellenas de liquido en sistemas de liberacion controlada mediante multiples recubrimientos.
US6986784B1 (en) 1999-05-14 2006-01-17 C. R. Bard, Inc. Implant anchor systems
US6719805B1 (en) 1999-06-09 2004-04-13 C. R. Bard, Inc. Devices and methods for treating tissue
US6855160B1 (en) 1999-08-04 2005-02-15 C. R. Bard, Inc. Implant and agent delivery device
US6491683B1 (en) 1999-09-07 2002-12-10 Alza Corporation Osmotic dosage form composed of an extruded polymer tube form
CA2393601A1 (fr) * 1999-12-09 2001-06-14 Alza Corporation Medication antivirale
WO2001047500A1 (fr) * 1999-12-23 2001-07-05 Pfizer Products Inc. Forme de dosage de medicament entraine par un hydrogel
US7232421B1 (en) 2000-05-12 2007-06-19 C. R. Bard, Inc. Agent delivery systems
US7204847B1 (en) 2000-07-28 2007-04-17 C. R. Bard, Inc. Implant anchor systems
US20060034922A1 (en) * 2000-11-03 2006-02-16 Andrx Labs, Llc Controlled release metformin compositions
US6790459B1 (en) 2000-11-03 2004-09-14 Andrx Labs, Llc Methods for treating diabetes via administration of controlled release metformin
US6866866B1 (en) * 2000-11-03 2005-03-15 Andrx Labs, Llc Controlled release metformin compositions
JP2002331522A (ja) * 2001-05-09 2002-11-19 Dai Ichi Kogyo Seiyaku Co Ltd 親水性樹脂粒状体の製造方法
GB0120835D0 (en) 2001-08-28 2001-10-17 Smithkline Beecham Plc Process
US6767200B2 (en) * 2001-09-28 2004-07-27 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US7217381B2 (en) * 2001-09-28 2007-05-15 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
BR0212951A (pt) * 2001-09-28 2004-10-26 Mcneil Ppc Inc Formas de dosagens compósitas
US7323192B2 (en) * 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US6837696B2 (en) * 2001-09-28 2005-01-04 Mcneil-Ppc, Inc. Apparatus for manufacturing dosage forms
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US6742646B2 (en) * 2001-09-28 2004-06-01 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US6982094B2 (en) * 2001-09-28 2006-01-03 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
AU2003241537A1 (en) * 2002-05-23 2003-12-12 Andrx Corporation Biguanide formulations
US6583225B1 (en) * 2002-06-21 2003-06-24 Isp Investments Inc. Polymeric hydrogels
AR039744A1 (es) * 2002-06-26 2005-03-09 Alza Corp Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
CA2490412A1 (fr) * 2002-06-28 2004-01-08 Alza Corporation Forme posologique orale comprenant une preparation de principe actif liquide et liberation prolongee de celle-ci par l'intermediaire d'une composition osmotique expansible
EP1534238A1 (fr) * 2002-07-29 2005-06-01 ALZA Corporation Formulations et formes posologiques pour une administration controlee de topiramate
US20050232995A1 (en) * 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
US7807197B2 (en) * 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
EP1556000A1 (fr) * 2002-10-31 2005-07-27 Alza Corporation Formulation pharmaceutique permettant d'augmenter la biodisponibilite de medicaments hydrophobes
US20040091538A1 (en) * 2002-10-31 2004-05-13 Crystal Pollock-Dove Dosage form providing ascending release of liquid formulation
US7135436B2 (en) * 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
US20050079220A1 (en) * 2003-07-31 2005-04-14 Betty Yu Osmotic engine & dosage form for controlled release of a liquid active agent formulation
CA2534920A1 (fr) * 2003-08-06 2005-02-24 Alza Corporation Administration reguliere de topiramate pendant une periode prolongee a formulation de dispersion amelioree
MXPA06002067A (es) * 2003-08-22 2006-08-11 Johnson & Johnson Suministro gradual de topiramato durante periodo prolongado.
WO2005020959A2 (fr) * 2003-09-02 2005-03-10 Alza Corporation Compositions medicamenteuses et formes pharmaceutiques de topiramate
KR20060115860A (ko) * 2003-09-26 2006-11-10 알자 코포레이션 활성 제제의 서방성 전달을 위한 ｏｒｏｓ 푸시-스틱
MXPA06003454A (es) * 2003-09-26 2006-08-31 Johnson & Johnson Formulaciones de liberacion controlada de analgesicos opioides y no opiodes.
CA2540044A1 (fr) * 2003-09-26 2005-04-07 Alza Corporation Forme posologique amelioree a liberation controlee comprenant un moteur attache
US8246986B2 (en) 2003-09-26 2012-08-21 Alza Corporation Drug coating providing high drug loading
WO2005030165A1 (fr) * 2003-09-26 2005-04-07 Alza Corporation Forme posologique destinee a la formulation d'un principe actif a liberation controlee
WO2005030182A1 (fr) * 2003-09-26 2005-04-07 Alza Corporation Formulations a liberation commandee presentant un taux croisssant de liberation
US20050074514A1 (en) * 2003-10-02 2005-04-07 Anderson Oliver B. Zero cycle molding systems, methods and apparatuses for manufacturing dosage forms
JP2007511519A (ja) * 2003-11-14 2007-05-10 アルザ・コーポレーシヨン 液状投薬形態物におけるトピラメートの制御放出
US20050175696A1 (en) * 2003-12-29 2005-08-11 David Edgren Drug granule coatings that impart smear resistance during mechanical compression
EP1701706A2 (fr) * 2003-12-29 2006-09-20 Alza Corporation Compositions medicamenteuses et formes pharmaceutiques
CA2550699A1 (fr) * 2003-12-29 2005-07-21 Alza Corporation, Inc. Nouvelles preparations de medicaments et formes posologiques de topiramate
US20050196442A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
US20050196448A1 (en) * 2004-03-05 2005-09-08 Hai Yong Huang Polymeric compositions and dosage forms comprising the same
US20050196447A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
US20050196446A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
KR20080005429A (ko) * 2005-04-19 2008-01-11 알자 코포레이션 트라마돌 및 가바펜틴을 포함하는 물질의 배합물
AR055099A1 (es) * 2005-07-28 2007-08-08 Alza Corp Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol
PL116330U1 (en) * 2005-10-31 2007-04-02 Alza Corp Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
WO2008052219A2 (fr) * 2006-10-27 2008-05-02 Goody Products, Inc. Outil de coiffure thérapeutique avec dispositif d'administration par injection
US7832413B2 (en) * 2006-10-27 2010-11-16 Goody Products, Inc. Therapeutic styling brush with infusion delivery
US7845360B2 (en) 2006-10-27 2010-12-07 Goody Products, Inc. Therapeutic styling brush with infusion delivery
US8524749B2 (en) * 2007-02-09 2013-09-03 Alza Corporation Controlled release compositions of tizanidine
CN102257120A (zh) * 2008-12-18 2011-11-23 Adds制药有限责任公司 吹塑薄壁的给药胶囊
WO2011021594A1 (fr) * 2009-08-18 2011-02-24 国立大学法人東北大学 Système d’administration de médicament à libération prolongée
US20130143867A1 (en) 2011-12-02 2013-06-06 Sychroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
CA2914365C (fr) 2013-06-05 2022-03-15 Synchroneuron, Inc. Formulations d'acamprosate, procedes d'utilisation de celles-ci, et combinaisons comprenant celles-ci

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2799241A (en) * 1949-01-21 1957-07-16 Wisconsin Alumni Res Found Means for applying coatings to tablets or the like
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4713243A (en) * 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
US4855141A (en) * 1988-03-25 1989-08-08 Alza Corporation Device comprising means for protecting and dispensing fluid sensitive medicament
US5213809A (en) * 1990-01-24 1993-05-25 Alza Corporation Delivery system comprising means for controlling internal pressure
KR920005648B1 (ko) * 1990-03-31 1992-07-11 정종평 항생활성 성분의 치과용 국소 지속성 투여 조성물
CA2098992A1 (fr) * 1991-01-30 1992-07-31 Patrick S. L. Wong Dispositif osmotique pour liberation-retard d'un agent
CA2065966A1 (fr) * 1991-04-23 1992-10-24 Robert J. Petcavich Articles jetables en plastique recyclable et melanges en resine synthetique moulable servant a leur fabrication
US5614578A (en) * 1994-10-28 1997-03-25 Alza Corporation Injection-molded dosage form

Also Published As

Publication number Publication date
KR100451782B1 (ko) 2004-10-08
KR20030097606A (ko) 2003-12-31
MX9703111A (es) 1997-07-31
US5614578A (en) 1997-03-25
EP1057478A3 (fr) 2001-09-19
ZA958892B (en) 1996-07-05
ES2203395T3 (es) 2004-04-16
DE69531263T2 (de) 2004-05-13
NZ295982A (en) 1998-05-27
KR100408103B1 (ko) 2004-04-14
CA2200746C (fr) 2007-11-20
EP0782440A1 (fr) 1997-07-09
DE69521901T2 (de) 2001-11-15
CA2200746A1 (fr) 1996-05-09
EP1057478B1 (fr) 2003-07-09
ATE244554T1 (de) 2003-07-15
AU3966095A (en) 1996-05-23
WO1996013248A1 (fr) 1996-05-09
DE69521901D1 (de) 2001-08-30
US5830502A (en) 1998-11-03
AU695739B2 (en) 1998-08-20
DE69531263D1 (de) 2003-08-14
KR970706793A (ko) 1997-12-01
ATE203396T1 (de) 2001-08-15
EP1057478A2 (fr) 2000-12-06
EP0782440B1 (fr) 2001-07-25
JPH10508023A (ja) 1998-08-04

Similar Documents

Publication Publication Date Title
CY2489B1 (en) Thermoplastic polymer membranes.
MY8700084A (en) Resilient cellular polymers comprising the reaction product of an amine terminated poly (alkylene oxide) and an epoxy resin
DE68906366D1 (en) Cd4-polypeptidderivate.
DE69115050D1 (de) Polymermembran.
IL82834A (en) Biodegradable polymeric materials based on polyether glycols,processes for the preparation thereof and surgical artiicles made therefrom
ZA922047B (en) Tacky,hydrophilic gel dressings and products therefrom
ATE197063T1 (de) Gleitfähige polymerzusammensetzungen
EP0277710A3 (en) Melt blown nonwoven web from fiber comprising an elastomer
TR28980A (tr) Hidrofilik polimer bilesimi ve bunu ihtiva eden ürün.
MY133022A (en) Thermoplastic silicone-containing hyrogels
FI953307L (fi) Biohajoavat termoplastiset polymeeriseoskoostumukset, joilla on nopeutettu biohajoaminen
DE69700406D1 (de) Statistische poly(oxypropylen/oxyethylen) polyole verwendbar zur herstellung von hochelastischen weichschaumstoffen mit verminderten schrumpfungstendenzen sowie daraus hergestellter schaumstoff
DE69114427D1 (de) Verbesserte Polymermembranen.
CA2400481A1 (fr) Sonde a ballonnet intra-aortique comportant une membrane du ballonnet ultrafine fabriquee par soufflage avec bi-etirage
DE69713216D1 (de) Heterogene Ionenaustauschmembran und Verfahren zu ihrer Herstellung
IL115827A (en) Poly(hydroxyarylene)-ligand-containing polymeric resin
FI941823L (fi) Kopolymeerejä, joissa on polyeetteriryhmiä
EP0618266A3 (fr) Masses à mouler thermoplastiques à base de polytéréphtalates d'alkylène, de polyméthane thermoplastique et de polymère caoutchouteux élastique.
WO1998025992A3 (fr) Films elastiques a biodegradabilite amelioree et leur procede de production
DE69019719D1 (de) Polymer- und Polypropylen-Harzzusammensetzung.
CA2207589A1 (fr) Copolymeres de polyether et leur procede de preparation
GB9020258D0 (en) Polymeric compositions & components therefore
WO1995013311A3 (fr) Composes coiffes pour electrolytes polymeres solides
WO1998050086A3 (fr) Dispositifs medicaux contenant des biomateriaux de polyurethane segmente
WO2002017972A3 (fr) Preparation d'articles steriles a partir de polymeres contenant un stabilisateur a base de poly(oxyalkylene)